Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726085 · ClinicalTrials.gov registry record · NA
Ibuprofen Versus Indomethacin Following Emergent Cerclage Placement
A NA study, sponsored by Woman's.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04726085 is a NA study that was terminated before completion, run by Woman's. The registered enrollment target is 11 participants.
The verdict
NCT04726085, a NA study, was terminated before completion, sponsored by Woman's.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Cervical insufficiency is defined as painless cervical dilation in the second trimester. Cervical insufficiency can ultimately lead to second trimester loss of pregnancy. Cerclages are utilized in pregnancies affected by cervical insufficiency in order to prolong gestational latency. There have been several studies investigating the efficacy of perioperative medications for cerclage placement and the effects they have on gestational latency. Some such studies have found that perioperative indomethacin in combination with antibiotics have significantly increased gestational latency when compared to placebo. Indomethacin has traditionally been the tocolytic of choice with cerclage placement. At our hospital, ibuprofen has been the tocolytic of choice for cerclage placement secondary to pharmacy availability. Our study aims to evaluate whether gestational latency differs among patients undergoing emergent cerclage whether they receive perioperative ibuprofen or indomethacin.
Interventions
- DRUG Indomethacin 150mg
- DRUG Ibuprofen 2400mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04726085
The ClinicalTrials.gov registry entry for NCT04726085 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woman's, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indomethacin 150mg is the first listed.
NCT04726085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04726085 about?
NCT04726085 is a clinical study titled "Ibuprofen Versus Indomethacin Following Emergent Cerclage Placement". Cervical insufficiency is defined as painless cervical dilation in the second trimester. Cervical insufficiency can ultimately lead to second trimester loss of pregnancy. Cerclages are utilized in pregnancies affected by cervical insufficiency in order to prolong gestational latency. There have been...
What is the current status of trial NCT04726085?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2021-02-01. Estimated completion is 2023-11-06.
What interventions are being tested in trial NCT04726085?
The interventions under investigation include: Indomethacin 150mg (DRUG), Ibuprofen 2400mg (DRUG).
Who is sponsoring clinical trial NCT04726085?
This trial is sponsored by Woman's, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.